| Financial Year |
March 31 2023 |
| Monetary Funds |
478,088,733.54 |
| Held-for-trading Financial Assets |
382,159,519.82 |
| Notes Receivable |
354,052,557.03 |
| Accounts Receivable |
2,433,378,476.25 |
| Advances to Suppliers |
142,322,595.39 |
| Other Receivables |
62,885,226.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,161,888,592.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,340,737.95 |
| Total Current Assets |
5,776,724,647.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
85,827,745.01 |
| Investment Properties |
643,787.35 |
| Fixed Assetes |
978,747,192.84 |
| Under-construction Projects |
154,649,778.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
542,953,641.03 |
| R&D expenses |
-- |
| Goodwill |
7,123,015.11 |
| Long-Term Deferred and Prepaid Expenses |
12,766,330.40 |
| Deferred Income Tax Assets |
72,067,871.38 |
| Other Non-Current Assets |
56,911,198.98 |
| Sub-Total of Non-Current Assets |
1,943,508,335.17 |
| Total Assets |
7,720,232,982.78 |
| Short-Term Loans |
56,729,024.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,202,414,868.34 |
| Accounts Payable |
943,328,988.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,761,533.38 |
| Taxes Payable |
68,873,187.24 |
| Interest Payable |
200,529.65 |
| Dividend Payable |
44,000.00 |
| Other payables |
58,338,532.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,018,343.92 |
| Other Current Liabilities |
135,274,186.76 |
| Sub-Total of Current Liabilities |
2,602,740,453.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,231,470.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,795,322.46 |
| Total Liabilities |
2,671,535,775.86 |
| Paid-In Capital(Or Share Stock) |
1,190,490,839.00 |
| Capital Surplus |
1,002,286,197.01 |
| Surplus Reserve |
225,674,624.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,542,403,819.57 |
| Minority Stockholder's Interest |
85,927,911.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,962,769,295.57 |
| Owner's Equity（Stockholder's Equity） |
5,048,697,206.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,720,232,982.78 |
